These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 110881)

  • 21. Suppression and patterns of recovery of serum immunoglobulins in mice treated with antibody directed against the constant region of heavy chains.
    Weill JC; Oriol R
    Ann Immunol (Paris); 1974; 125 C(5):705-14. PubMed ID: 4142371
    [No Abstract]   [Full Text] [Related]  

  • 22. Control of J chain biosynthesis in relation to heavy and light chain synthesis, polymerization and secretion.
    Kaji H; Parkhouse ME
    J Immunol; 1975 Apr; 114(4):1218-20. PubMed ID: 804006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serologic and structural characterization of immunoglobulin chains secreted by rabbit-mouse hybridomas.
    Yarmush ML; Gates FT; Dreher KL; Kindt TJ
    J Immunol; 1981 Jun; 126(6):2240-4. PubMed ID: 6785349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis but not secretion of J chain by variant mouse myeloma cells which lose alpha-chain-synthesizing ability.
    Mosmann T; Baumal R
    J Immunol; 1975 Oct; 115(4):955-62. PubMed ID: 809509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in mouse myeloma cells: implications for human multiple myeloma and the production of immunoglobulins.
    Weitzman S; Margulies DH; Scharff MD
    Ann Intern Med; 1976 Jul; 85(1):110-6. PubMed ID: 820230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of protein structure and immunoglobulin gene organization in the light of two new deleted heavy chain disease proteins.
    Franklin EC; Kyle R; Seligmann M; Frangione B
    Mol Immunol; 1979 Nov; 16(11):919-21. PubMed ID: 118919
    [No Abstract]   [Full Text] [Related]  

  • 27. Primary and secondary variants in immunoglobulin heavy chain production.
    Koskimies S; Birshtein BK
    Nature; 1976 Dec; 264(5585):480-2. PubMed ID: 826832
    [No Abstract]   [Full Text] [Related]  

  • 28. The use of liquid and gel isoelectric focusing as a means of further evaluating the degree of restriction of rabbit antibodies.
    Freedman M; Milandre J; Yeger H
    J Immunol Methods; 1974 Dec; 6(1-2):165-76. PubMed ID: 4154957
    [No Abstract]   [Full Text] [Related]  

  • 29. Mouse myeloma mutants blocked in the assembly, glycosylation and secretion of immunoglobulin.
    Weitzman S; Scharff MD
    J Mol Biol; 1976 Apr; 102(2):237-52. PubMed ID: 818392
    [No Abstract]   [Full Text] [Related]  

  • 30. DNA rearrangements in MPC-11 immunoglobulin heavy chain class-switch variants.
    Eckhardt LA; Tilley SA; Lang RB; Marcu KB; Birshtein BK
    Proc Natl Acad Sci U S A; 1982 May; 79(9):3006-10. PubMed ID: 6806822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different ways to modify monoclonal antibodies.
    Köhler G; Baumann B; Iglesias A; McCubrey J; Potash MJ; Traunecker A; Zhu D
    Med Oncol Tumor Pharmacother; 1984; 1(4):227-33. PubMed ID: 6544903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletions in immunoglobulin mu chains.
    Köhler G; Potash MJ; Lehrach H; Shulman MJ
    EMBO J; 1982; 1(5):555-63. PubMed ID: 6329690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hybrid gamma 2b-gamma 2a genes expressed in myeloma variants: evidence for homologous recombination.
    Tilley SA; Eckhardt LA; Marcu KB; Birshtein BK
    Proc Natl Acad Sci U S A; 1983 Nov; 80(22):6967-71. PubMed ID: 6316338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and characterization of a variant of mouse plasmacytoma J558 synthesizing a 110,000-dalton immunoglobulin heavy chain and of secondary variants synthesizing either a 55,000-dalton or an 80,000-dalton immunoglobulin heavy chain: possible implications.
    Matsuuchi L; Morrison SL
    Mol Cell Biol; 1982 Sep; 2(9):1134-44. PubMed ID: 6184610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-specific expression of secreted versus membrane forms of immunoglobulin gamma 2b mRNA involves selective use of alternate polyadenylation sites.
    Milcarek C; Hall B
    Mol Cell Biol; 1985 Oct; 5(10):2514-20. PubMed ID: 3939252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Derivation and diversification of monoclonal antibodies.
    Köhler G
    EMBO J; 1985 Jun; 4(6):1359-65. PubMed ID: 3928369
    [No Abstract]   [Full Text] [Related]  

  • 37. Independent immunoglobulin class-switch events occurring in a single myeloma cell line.
    Eckhardt LA; Birshtein BK
    Mol Cell Biol; 1985 Apr; 5(4):856-68. PubMed ID: 3921826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assembly and secretion of heavy chains that do not associate posttranslationally with immunoglobulin heavy chain-binding protein.
    Hendershot L; Bole D; Köhler G; Kearney JF
    J Cell Biol; 1987 Mar; 104(3):761-7. PubMed ID: 3102505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A.
    Sun LK; Curtis P; Rakowicz-Szulczynska E; Ghrayeb J; Chang N; Morrison SL; Koprowski H
    Proc Natl Acad Sci U S A; 1987 Jan; 84(1):214-8. PubMed ID: 3025856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloma mutant with a novel 3' flanking region: loss of normal sequence and insertion of repetitive elements leads to decreased transcription but normal processing of the alpha heavy-chain gene products.
    Gregor PD; Morrison SL
    Mol Cell Biol; 1986 Jun; 6(6):1903-16. PubMed ID: 3023910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.